Ofatumumab (Kesimpta) Pre-Filled Pen 20mg Homecare Supply

This procurement opportunity is for Ofatumumab (Kesimpta) Homecare, a pre-filled pen injection containing 20 mg of ofatumumab in 0.4 mL volume. Suppliers should be prepared to provide single pen packs suitable for at-home self-administration. This is a B-cell depleting monoclonal antibody used in the treatment of relapsing multiple sclerosis. Qualified suppliers must demonstrate capacity to deliver pharmaceutical products meeting regulatory standards, maintain proper cold chain logistics, and ensure product authenticity and traceability. Interested vendors should provide pricing, delivery timelines, and documentation of product certification and licensing.